MedTrace Logo

Diabetes teleMonitoring of Patients in Insulin Therapy

NCT04981808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 331

Last updated 2024-01-31

No results posted yet for this study

Summary

The trial is an open-label randomized controlled trial. Patients with T2D on insulin therapy will be randomized to a telemonitoring group (intervention) and a usual care group (control). The telemonitoring group will use various devices at home. Hospital staff will monitor their data for a period of three months.

Conditions

  • Type 2 Diabetes Treated With Insulin

Interventions

DEVICE

Telemonitoring

Telemonitoring of CGM and insulin pen data

Sponsors & Collaborators

  • Steno Diabetes Center Sjaelland

    collaborator OTHER_GOV

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Glooko

    collaborator INDUSTRY

  • DexCom, Inc.

    collaborator INDUSTRY

  • Aalborg University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-18
Primary Completion
2023-11-24
Completion
2023-11-24

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981808 on ClinicalTrials.gov